Press release
University of Dundee researchers hope to turn their spinout venture into a biotech company worth hundreds of millions of pounds by helping to treat people with eczema, rheumatoid arthritis and other inflammatory conditions.
Press release
University of Dundee researchers hope to turn their spinout venture into a biotech company worth hundreds of millions of pounds by helping to treat people with eczema, rheumatoid arthritis and other inflammatory conditions.
Press release
The Universities of Dundee and Edinburgh are playing key roles in a €77.7 million pan-European consortium seeking to accelerate the development of therapies for Covid-19 and future coronaviruses.
Feature
Almost twenty years after deciphering the human genome, our understanding of human disease is still far from complete.
Press release
The University of Dundee is working with partners around the world to rapidly repurpose existing drugs against Covid-19.
Press release
University spinout, Amphista Therapeutics, has announced a multi-million pound funding package.
Press release
A project to grow the Tay Cities BioMedical cluster of world-class life sciences companies will generate hundreds of millions of pounds for the local economy.
Press release
An entrepreneurial scientist from the University of Dundee has proven his business concept is more than skin deep after winning one of the country’s top enterprise awards
Press release
The University of Dundee Drug Discovery Unit is delighted to announce it has licensed assets to Corbin Therapeutics to develop possible new treatments for neuroinflammation-based disorders, including multiple sclerosis (MS).
Press release
Exscientia, a world leader in artificial intelligence (“AI”) driven drug discovery and a spinout company of the University of Dundee announced today that it has entered a three-year AI drug discovery partnership with leading biopharma company Celgene
News
Evotec invests in Exscientia to advance AI-driven drug discovery
News
A new diagnostic test developed from research at the Universities of Dundee and Cambridge has been launched with the aim of helping eliminate the disease known as African sleeping sickness.
News
Pre-clinical collaboration focused on up to 10 targets nominated by GSK